(Press-News.org) DURHAM, N.C. -- Aspirin has been widely used for more than 50 years as a common, inexpensive blood thinner for patients with heart disease and stroke, but doctors have little understanding of how it works and why some people benefit and others don't.
Now researchers at Duke Medicine have solved some of the mysteries related to the use of this century-old drug, and developed a blood-based test of gene activity that has been shown to accurately identify who will respond to the therapy.
The new gene expression profile not only measures the effectiveness of aspirin, but also serves as a strong predictor of patients who are at risk for heart attack, according to a study appearing July 3, 2013, in the online edition of the Journal of the American College of Cardiology.
"We recognized the concept of aspirin resistance among a population of patients who have cardiac events or stroke," said senior author Geoffrey S. Ginsburg, M.D., PhD, director of genomic medicine at Duke's Institute for Genome Sciences & Policy and executive director of the Center for Personalized Medicine. "We give the same dose to all patients, but maybe some patients need a larger dose of aspirin, or maybe they need to try a different therapy entirely. We need better tools to monitor patients and adjust their care accordingly, and the findings from our study move us in that direction."
The Duke researchers enlisted three groups of participants – two of healthy volunteers and one comprised of patients with heart disease seen in outpatient cardiology practices.
The healthy volunteers were given a dosage of 325 mg of aspirin daily for up to a month; the heart disease patients had been prescribed a low dose of aspirin as part of their treatment. Blood was then analyzed for the impact of aspirin on RNA expression and the function of platelets, which are the blood cells involved in clotting.
The RNA microarray profiling after aspirin administration revealed a set of 60 co-expressed genes that the researchers call the "aspirin response signature," which consistently correlated with an insufficient platelet response to aspirin therapy among the healthy subjects as well as the heart disease patients.
The researchers also examined the aspirin response signature in another group of patients who had undergone cardiac catheterizations. They found the signature was also effective in identifying those patients who eventually suffered a heart attack or died.
"The aspirin response signature can determine who is at risk for heart attack and death," said Deepak Voora, M.D., assistant professor of medicine at Duke and lead author of the study. "There is something about the biology of platelets that determines how well we respond to aspirin and we can now capture that with a genomic signature in blood."
Ginsburg said the research is progressing to recreate the findings in other populations, and to develop a standardized testing system that could one day move the analysis into daily practice.
"Nearly 60 million people take aspirin regularly to reduce their chances of heart attack and death, but it doesn't work for everyone," said Rochelle Long, Ph.D., of the National Institutes of Health's National Institute of General Medical Sciences, which partly supported the study. "By monitoring gene activity patterns these investigators uncovered a 'signature' linked to inadequate responsiveness. This work may eventually lead to a simple blood test to identify those who do not benefit from aspirin, enabling them to seek other therapeutic options."
INFORMATION:
In addition to Ginsburg and Voora, study authors include Derek Cyr; Joseph Lucas; Jen-Tsan Chi; Jennifer Dungan; Timothy A. McCaffrey; Richard Katz; L. Kristin Newby; William E. Kraus; Richard C. Becker; and Thomas L. Ortel.
The study received funding from the Duke Institute for Genome Sciences & Policy; the National Institutes of Health (T32HL007101 to DV); the National Center for Research Resources (UL1RR024128); the National Institutes of General Medical Sciences (RC1GM091083); the Centers for Disease Control and Prevention (5U01DD000014); and the David H. Murdock Research Institute.
Biomarker predicts heart attack risk based on response to aspirin therapy
2013-07-04
ELSE PRESS RELEASES FROM THIS DATE:
Archaeologists unearth carved head of Roman god in ancient rubbish dump
2013-07-04
An 1,800-year-old carved stone head of what is believed to be a Roman god has been unearthed in an ancient rubbish dump.
Archaeologists made the discovery at Binchester Roman Fort, near Bishop Auckland in County Durham, England.
First year Durham University archaeology student Alex Kirton found the artefact, which measures about 20cm by 10cm, in buried late Roman rubbish within what was probably a bath house.
The sandstone head, which dates from the 2nd or 3rd century AD, has been likened to the Celtic deity Antenociticus, thought to have been worshipped as a source ...
Clues about autism may come from the gut
2013-07-04
Bacterial flora inhabiting the human gut have become one of the hottest topics in biological research. Implicated in a range of important activities including digestion, fine-tuning body weight, regulating immune response, and producing neurotransmitters affect that brain and behavior, these tiny workers form diverse communities. Hundreds of species inhabit the gut, and although most are beneficial, some can be very dangerous.
In new research appearing in the journal PLOS ONE, a team led by Rosa Krajmalnik-Brown, a researcher at Arizona State University's Biodesign Institute, ...
Homicide by mentally ill falls, but patient suicide rises in England
2013-07-04
The number of people killed by mental health patients has fallen to its lowest level in a decade -- figures released today show.
Experts suggest the fall in homicide reflects safer patient care and point to the possible effect of better treatment of drug and alcohol problems as well as new legal powers in the community.
But suicides among mental health patients increased with the current economic difficulties a likely factor.
The findings, reported in the National Confidential Inquiry into Suicide and Homicide by People with Mental Illness (NCI) produced by The ...
Improved outlook for immune-based therapies
2013-07-04
The idea of fighting infections and even cancers by inducing protective immune responses may now be a step closer to clinical practice. Researchers have removed a major obstacle to widespread use of so-called adoptive transfer therapy, in which a patient receives "killer" immune cells targeting a disease agent. Existing technologies can easily provide T cells that will recognize a specific antigen, but it has been challenging to identify individual cells most likely to succeed in fighting the disease – until now.
Scientists at the Technische Universitaet Muenchen (TUM) ...
Genetic signals reflect the evolutionary impact of cholera
2013-07-04
An international research team has used a novel approach to identify genetic factors that appear to influence susceptibility to cholera. The findings by investigators from Massachusetts General Hospital (MGH), the Broad Institute and the International Center for Diarrhœal Disease Research, Bangladesh (ICDDR,B) indicate the importance of pathways involved in regulating water loss in intestinal cells and of the innate immune system in the body's response to the bacteria that causes cholera, which affects from 3 to 5 million people each year and causes more than 100,000 deaths. ...
First comprehensive regulatory map is a blueprint for how to defeat tuberculosis
2013-07-04
Despite decades of research on the bacterium that causes tuberculosis (TB), scientists have not had a comprehensive understanding of how the bacterium is wired to adapt to changing conditions in the host. Now, researchers at Stanford University, Seattle BioMed, Boston University and the Broad Institute, Max Planck Institute of Biology in Berlin, Germany, Caprion Proteomics Inc. in Montreal, Canada, Brigham and Woman's Hospital (Harvard University), and Colorado State University have taken the first steps toward a complete representation of the regulatory network for Mycobacterium ...
Evidence suggests Antarctic crabs could be native
2013-07-04
A new study has cast doubt on the claim that crabs may have disappeared from Antarctica only to return due to warming seas.
The theory surfaced two years ago following the discovery of a major colony of King crabs (Lithodidae) in the Palmer Deep, a basin in the continental shelf off the Antarctic Peninsula. It was thought the species may have left the continent between 40 and 15 million years ago and was returning as seawater temperatures rose. Fears were expressed that its reintroduction would decimate other fauna in the region.
But an extensive study of all known ...
Cockatoos 'pick' puzzle box locks
2013-07-04
A species of Indonesian parrot can solve complex mechanical problems that involve undoing a series of locks one after another, revealing new depths to physical intelligence in birds.
A team of scientists from Oxford University, the University of Vienna, and the Max Planck Institute, report in PLOS ONE a study in which ten untrained Goffin's cockatoos [Cacatua goffini] faced a puzzle box showing food (a nut) behind a transparent door secured by a series of five different interlocking devices, each one jamming the next along in the series.
To retrieve the nut the birds ...
Animal master-burglars: Cockatoos show technical intelligence on a 5-lock problem
2013-07-04
Solving one problem in order to gain access to another, which will enable you to address a third problem (and so on) in order to finally reach a goal – so-called sequential problem solving – is considered to be cognitively highly challenging as it requires the ability to spatially and mentally distance oneself from a desired goal.
In the study, ten untrained cockatoos faced a puzzle box showing a nut behind a transparent door closed by five different interlocking devices, each one jamming the next along the series and each required different motor actions in order to ...
Bacteria communicate to help each other resist antibiotics
2013-07-04
New research from Western University unravels a novel means of communication that allows bacteria such as Burkholderia cenocepacia (B. cenocepacia) to resist antibiotic treatment. B. cenocepacia is an environmental bacterium that causes devastating infections in patients with cystic fibrosis (CF) or with compromised immune systems.
Dr. Miguel Valvano and first author Omar El-Halfawy, PhD candidate, show that the more antibiotic resistant cells within a bacterial population produce and share small molecules with less resistant cells, making them more resistant to antibiotic ...